Besides, it has been reported that high avidity T cells employed in anti-tumor therapy tend to secrete Th1 pro-inflammatory cytokines whereas low avidity ones show a Th2 pattern28, suggesting that the Th1/Th2/Th17 cell balance might influence the avidity of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.